[1]
Shayegan, B., Zukotynski, K., Bénard, F., Ménard, C., Kuk, J., Sistani, G., Bauman, G., Veit-Haibach, P. and Metser, U. 2021. Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/ computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer. Canadian Urological Association Journal. 15, 6 (Mar. 2021), 162-72. DOI:https://doi.org/10.5489/cuaj.7268.